My primary research interest lies in the field of solid tumor cancer immunotherapy and its application in translational research with a focus on:

• Development of alternative immune checkpoint inhibitors
• Improvement of current immune checkpoint therapies
• Generation of antigen-specific dendritic-cell based vaccination strategies
• Discovery of nanoparticle-based cancer immunotherapy applications
• mRNA-based cancer vaccines